Exceptionally strong intermolecular association in hydrophobic DNA minor groove binders and their potential therapeutic consequences by Parkinson, John A et al.
Strathprints Institutional Repository
Parkinson, John A and Scott, Fraser J and Suckling, Colin J and Wilson, Gail (2013) Exceptionally
strong intermolecular association in hydrophobic DNA minor groove binders and their potential
therapeutic consequences. MedChemComm, 4 (7). pp. 1105-1108.
Strathprints is designed to allow users to access the research output of the University of Strathclyde.
Copyright c© and Moral Rights for the papers on this site are retained by the individual authors
and/or other copyright owners. You may not engage in further distribution of the material for any
profitmaking activities or any commercial gain. You may freely distribute both the url (http://
strathprints.strath.ac.uk/) and the content of this paper for research or study, educational, or
not-for-profit purposes without prior permission or charge.
Any correspondence concerning this service should be sent to Strathprints administrator:
mailto:strathprints@strath.ac.uk
http://strathprints.strath.ac.uk/
Exceptionally strong intermolecular association in
hydrophobic DNA minor groove binders and their
potential therapeutic consequences†
John A. Parkinson, Fraser J. Scott, Colin J. Suckling* and Gail Wilson
An antibacterial DNA minor groove binder is shown by NOE experiments to self-associate in aqueous
solution at temperatures up to 80 C in an anti-parallel, head-to-tail orientation as found in binding to
duplex DNA oligomers.
Introduction
Minor groove binders for DNA have been shown to possess many
biological properties, in particular antibacterial activity.1,2 One of
the most potent series includesmolecules based loosely upon the
structure of the natural product, distamycin, 1, in which the N-
terminal formyl group has been replaced by an aromatic ring and
one of the amide links replaced by the isosteric alkene as repre-
sented by 2–4.3 Compounds 2–4 are all signicantly active against
many Gram positive bacteria (MIC in range 0.12–5 mM) and 4 is
more eﬀective than vancomycin against many strains of resistant
bacteria;3,4 4 is in late stage pre-clinical development. Although
the full mechanism of antibacterial activity of these compounds
has not been established, there is a strong correlation between
DNA binding and antibacterial activity.1,5 For example, the
naphthyl analogue of 4, 5, is neither signicantly active as an
antibacterial agent nor a strong binder to DNA oligomers.3
Distamycin and its analogues were rst shown to bind in a
head-to-tail, anti-parallel mode within the DNAminor groove by
NMR studies of a 2 : 1 complex with the non-self-complemen-
tary duplex d(CGCAAATTGGC)$d(GCCAATTTGCG).6 This mode
of DNA binding has subsequently been shown to predominate
for distamycin-related classes of small molecule.7,8 Studies in
our laboratory that have used NMR data to conrm structural
details agree with this,3,9–14 and have attempted to address
questions raised about sequence specicity and the thermody-
namics of binding.11 Thermo-chemical studies of the binding of
a number of minor groove binders to DNA and molecular
dynamics simulations have suggested that a minor groove
binder should associate with DNA from aqueous solution as a
pre-formed, self-assembled dimer.13 Several types of intermo-
lecular forces can be considered to steer the association of these
minor groove binders including hydrophobic interactions,
specic hydrogen bonding, face-to-face p-stacking, p-cation,
and dipole–dipole interactions. Aggregation of ligands in free
solution capable of binding to the DNA-minor groove as face-to-
face dimers have been reported widely in the literature.15
However, conclusive experimental proof concerning the
detailed structural arrangement of the free-solution associa-
tions of the type of ligands concerned in these studies (1–6) has
not been reported. Such detailed information would be relevant
not only for understanding the DNA binding mechanism but
also for tailoring the design and formulation of drug candi-
dates, where aggregation is likely to substantially inuence
physicochemical properties.
Results
Investigations of the solution properties of these potent anti-
biotics were based on 2, which was selected for study because of
its mono-basicity (thereby reducing the potential complexity of
ionic states during self-association) and because the structure
of its 2 : 1 complex with the DNA oligomer d(CGATATATCG)2 is
already known (Fig. S1†).3,14 Although 2 is not the most active
antibacterial compound of the set, its 1H NMR spectrum is
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suﬃciently resolved to permit essentially complete resonance
assignment, a requirement when assessing solution structures.
For the clinical candidates 3 and 4 this is not the case. However
all three compounds, 2, 3, and 4, have very similar solution
behaviour at the macroscopic level so that molecular interac-
tions deduced for 2 can reasonably be extended to 3 and 4. For
these experiments, the mono-hydrochloride of 2 was prepared
from the pure free base by repeated freeze-drying from dilute
hydrochloric acid. Its 1H NMR spectrum in aqueous solution
(90% H2O/10% D2O, 5 mM) at 25 C was found to be broad and
largely featureless, a characteristic of substantial self-associa-
tion (conrmed by negative NOEs), and signals were not
assignable with any degree of certainty (Fig. S2†).
The behaviour of 2 in aqueous solution was subsequently
measured as a function of temperature. Although little change in
resolution was observed at increasing temperatures, linewidths
reduced suﬃciently to allow NMR data [1D 1H, 2D [1H, 1H] COSY,
TOCSY, NOESY and 2D [1H, 13C] HSQC] to be acquired at 80 C.
These were suﬃciently resolved to permit the assignment of
some key resonances (Fig. 1). This assignment was partially
achieved by monitoring resonance shape and chemical shi at
ambient temperature following the sequential addition of
aliquots of DMSO-d6 to aqueous solutions of 2 and making
comparisons with fully assigned data for 2 solubilized exclusively
in DMSO-d6 (Fig. 1 and S3†). Several important assignments were
conclusively mapped between data acquired for 2 solubilized in
both DMSO-d6 at 25 C and water at 80 C. By this approach
1H
NMR resonances Hs8, amide NH9, pyrrole H14, and N-methyl
H16 protons were identied. These atoms are located towards
either the C-terminus or N-terminus of 2 (Fig. 1a).
Studies of the interactions between drug molecules using one
and two-dimensional NMR spectroscopy have been reported in
part with the aim of understanding the basis of the therapeutic
eﬀects of combinations of drugs in cancer chemotherapy.16–18
Subsequent study of the 2D [1H, 1H] NOESY NMR spectrum of 2
yielded several identiable cross-peak assignments which could
bemapped onto intra- and inter-molecular interactions (Fig. S4†).
Intramolecular NOEs were observed between signals from H13
and H14, and between signals for H13 and H16 of the N-methyl
group of the same pyrrole ring. NOEs from H14 and H16 were
observed to H17. An NOE response was also observed between
NH9 and H8. These observations are consistent with the curved,
planar character of 2 and relate to protons close to one another
consistent with the covalent structure. More notably, NOE
correlations were also observed between H8 and H16, and
between NH9 and H14. In both instances, these proton pairs are
too far separated for intra-molecular NOEs to occur, especially at
the short mixing times used in the experiments and accounting
for potential spin-diﬀusion. However, by considering 2 to be
predominantly paired as a head-to-tail, face-to-face dimer in
aqueous solution, the NOEs can be fully satised structurally,
thereby providing evidence for intermolecular association of 2 as
shown schematically in Fig. 2.
It is of interest to consider whether or not head-to-tail, face-
to-face dimerisation is an intrinsic property of 2 and related
minor groove binders in the absence of a DNA template. The
assembly process was investigated by means of a molecular
dynamics simulation. A model of 2 in the form of a pdb le was
prepared and imported into the AMBER molecular modelling
soware package and solvated using an explicit box of water.19
The assembly of molecules was energy-minimised, run under
Fig. 1 Assigned 1H NMR data from 2 acquired at 600 MHz. (a) Chemical structure
of 2 with atom numbering used in the data assignment. (b) 1H NMR spectrum of 2
in 90% H2O/10% D2O at 80 C. (c)
1H NMR spectrum of 2 in DMSO-d6. Expansions
are shown for the region d1H ¼ 6.5–8.5 ppm. Selective signal assignments are
shown for both sets of conditions and coloured diﬀerently for the avoidance of
confusion. Coloured arrows indicate peaks relevant to intermolecular NOE obser-
vations shown in Fig. 2. For full signal assignments see Table S1 in the ESI.†
Fig. 2 Proposed structure of dimer of 2 interpreted from NOE spectrum. The
coloured lines match the coloured arrows in Fig. 1.














































MD conditions by rst equilibrating and then running under
production conditions according to standard protocols devel-
oped at Strathclyde for investigating ligand binding to duplex
DNA in the minor groove.11 Within 50 ps of the production run
starting, the two molecules of 2 were observed to interact, very
swily forming a dimer consistent with the structure deduced
from the experimental NMR data. The dimer remained assem-
bled in this form for the remainder of the production run
without dissociation (Fig. S5 and video clip†).
Discussion
Aggregation of 2 as head-to-tail, face-to-face dimers is consis-
tent with several observations. Firstly, pre-association as a
dimer in dilute aqueous solution would support a low dissoci-
ation constant for 2 and its DNA target. Indeed values in the
range 1–10 nM are typical for minor groove binders in the
Strathclyde library.13 Secondly, in the series containing alkene
linkages represented by 2–4, unusually low pKas for the mor-
pholinoethyl group have been measured, a feature that is
explained by the self-association (Table 1). Notably, the minor
groove binder 6, which is also antibacterial, has more normal
pKas for both of the basic functional groups. Thirdly, whilst the
solubility of 2–4 is high at pH less than 4 (>100 mgmL1), as the
pH was raised to between 4 and 5, all three compounds formed
gels over a period of 30 minutes to several hours. Gel formation
was retarded by the addition of excipients such as mannitol,
hydroxyethyl-b-cyclodextrin and especially glucose 6-phosphate
but could not be avoided. These results, including the appear-
ance of the NMR spectra at or near room temperature, are
strongly suggestive of extended dimer aggregates.
The exceptional aggregation characteristics of 2 may be put
into their full context by comparing these results with those
recorded for a range of related compounds that aggregate to
lesser but varying degrees. 9 self-assembles with an association
constant, Kass ¼ 6.1  104 M1 that was determined by NMR
spectroscopy.13b Without the nicotinamide headgroup
(compounds 7 and 8), Kass is lower by an order of magnitude (i.e.
103 M1). This is reected qualitatively by the 1H NMR spectrum
linewidths and NOE responses observed: when association is
weaker, linewidths are much narrower and the NOE response is
either weak or absent. 10, a truncated form of 2, gives narrower
(relative to 2) but resolved 1H NMR resonances at room
temperature and strong negative NOEs. Based on the similarity
between data for 10 and that of 9, we expect Kass for 10 to be of
the order of 104 to 105 M1 according to our preliminary
diﬀusion measurements. The 1H NMR linewidths for 2 are
almost twice those of 10 (Fig. S6†) suggesting a Kass of the order
of at least 105 M1. We are currently attempting to quantify the
self-association of these compounds as part of a wider study, the
results of which shall be reported in due course.
With respect to their application as antibacterial drugs, dimer
formation and extended aggregation have substantial conse-
quences. Several experimental studies using a range of physical
methods including NMR and a molecular modelling have
demonstrated the association of drug molecules with a high
degree of planarity and consequentially lowered bioavailability
and cell penetration.16–18One such study concernedminor groove
binders of a diﬀerent class (terbenzimidazoles) from the Strath-
clyde library of distamycin derivatives, in which higher cellular
activity was associated with lower aggregation.17 All these studies,
however, investigated combinations of drugs with signicant
anti-cancer activity. The antibacterial activity of 2–4 is limited by
their cell penetration. All have signicant activity against a wide
range ofGrampositive bacteria but are essentially inactive against
Gram negative bacteria.3,9 The uorescence of these diarylalkenyl
minor groove binders has made it possible to demonstrate that
they do not accumulate in Gram negative bacterial cells.
Together, these results imply that 2–4 do not enter Gramnegative
bacterial cells, an observation that is most likely associated with
their large size as dimers. The probability that a compound with
these physicochemical characteristics will be an orally active
bioavailable drug has been estimated at about 5% by evaluating a
data set of 100 000 compounds20 and indeed the formulation of
the most active compound and clinical lead, 4, is a challenge
because of gelation above pH 4. However, for the initial intended
use, these properties can be turned to advantage. In studies of
oral bioavailability in hamsters for the treatment of Clostridium
diﬃcile infections in the gastro-intestinal tract, it has been found
that negligible quantities (18–263 ng mL1) of minor groove
binder 4were detectable in plasma leaving the vastmajority of the
dose available to treat the infection.21
Conclusions
Strong dimerisation in dilute aqueous solution has been
demonstrated for alkene-containing minor groove binders
exemplied by 2–4. The eﬀect of dimerisation is manifested in
the formulation and bioavailability of the most active
compound 4, but with careful attention to formulation and
dosing, 4 has been shown to have great promise as a treatment
for resistant Gram positive bacteria, in particular Clostridium
diﬃcile.21
Table 1 Measured pKa values of antibacterial minor groove binders
Compound 2 3 4 6
pKa 1 NA 3.49 4.38 8.44
pKa 2 6.04 5.26 6.02 9.12
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